Skip to content

iRhythm Holdings, Inc. IRTC Change in Deferred Revenue

Change in Deferred Revenue at other companies

Cytokinetics logo
CytokineticsCYTK
$41K
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$35M+151%
OSI Systems logo
OSI SystemsOSIS
$19.3M+226%

Other financials

Income statement

See full
Revenue$199.4M+25.7%
Gross profit$141.4M+29.4%
Operating income-$16.2M+50.3%
Net income-$13.9M+54.6%
EPS (diluted)-$0.43+55.7%

Balance sheet

See full
Cash & equivalents$248.5M-35.2%
Total debt$79.0M-10.5%
Total equity$161.2M+86.0%
Total assets$1.0B+8.7%

Cash flow

See full
Operating cash flow-$26.2M-232%
CapEx$6.9M-26.7%
Free cash flow-$33.1M-91.1%

Valuation

See full
Market cap$3.62B+16.0%

Profitability

See full
Gross margin71%+1.6pp
Operating margin-5.5%-2.2pp
Net margin-7.3%-3.1pp
FCF margin2.4%

Returns & leverage

See full
Return on equity-53.1%-17.4pp
Debt / equity0.5×-0.5×
Current ratio5.2×-0.5×

Where this comes from

Reported directly by iRhythm Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: iRhythm Holdings, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRhythm Holdings, Inc. 's change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRhythm Holdings, Inc. 's change in deferred revenue?
iRhythm Holdings, Inc. (IRTC) reported change in deferred revenue of -$145K in Q1 2026.
How has iRhythm Holdings, Inc. 's change in deferred revenue changed year-over-year?
iRhythm Holdings, Inc. 's change in deferred revenue decreased by 141.4% year-over-year, from $350K to -$145K.
What does change in deferred revenue mean?
Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.